GLI1 and neoplasm: Tumor-derived GLI1 sustains expansion and invasion of PMN-MDSCs in vitro, and promotes their immunosuppressive activity on T cells, inhibiting their effector capability, as demonstrated by the reduced production of IFNγ by CD4 + and CD8 + T cells.